Literature DB >> 2970521

Lymphokine production by murine T cells in the mixed leukocyte reaction.

E Puré1, K Inaba, J Metlay.   

Abstract

Although the production of B cell stimulatory factors by cell lines and hybridomas is well established, production of specific lymphokines by normal T cells in response to antigen stimulation has not been analyzed. We have used bioassays and neutralizing mAbs to demonstrate that IL-2, IL-4, and B cell growth factors (BCGF) are produced during primary and secondary MLRs. IL-2 is detected in the first 12 h of both types of MLR. IL-4 and BCGF appear at 24-48 h in the conditioned medium of the primary MLR, and peak by 12 h in the secondary MLR. The amount of IL-4 in the primary response reaches a level that is 10% of that detected in the secondary. In contrast, BCGF production steadily increases over time in the primary MLR, and maximal production is equivalent to that made in the secondary response. Allogeneic dendritic cells and anti-Ig-activated B blasts both stimulated lymphokine production in the primary MLR, whereas small B cells were weak. In the secondary MLR, all three cell populations stimulated the production of IL-2, IL-4, and BCGF. Therefore, the release of several defined B cell stimulating factors can be detected in the conditioned media of responding primary T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970521      PMCID: PMC2189013          DOI: 10.1084/jem.168.2.795

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

Review 1.  Molecular regulation of B lymphocyte response.

Authors:  T Kishimoto; T Hirano
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

2.  Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1.

Authors:  J Ohara; W E Paul
Journal:  Nature       Date:  1985 May 23-29       Impact factor: 49.962

3.  Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression.

Authors:  P D Murray; D T McKenzie; S L Swain; M F Kagnoff
Journal:  J Immunol       Date:  1987-10-15       Impact factor: 5.422

4.  Interleukin 4 (B-cell growth factor II/eosinophil differentiation factor) is a mitogen and differentiation factor for preactivated murine B lymphocytes.

Authors:  A O'Garra; D J Warren; M Holman; A M Popham; C J Sanderson; G G Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.

Authors:  H M Cherwinski; J H Schumacher; K D Brown; T R Mosmann
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

6.  Direct activation of CD8+ cytotoxic T lymphocytes by dendritic cells.

Authors:  K Inaba; J W Young; R M Steinman
Journal:  J Exp Med       Date:  1987-07-01       Impact factor: 14.307

7.  Antigen presentation by resting B cells. Radiosensitivity of the antigen-presentation function and two distinct pathways of T cell activation.

Authors:  J D Ashwell; A L DeFranco; W E Paul; R H Schwartz
Journal:  J Exp Med       Date:  1984-03-01       Impact factor: 14.307

8.  Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release.

Authors:  K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

9.  B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes.

Authors:  J Hu-Li; E M Shevach; J Mizuguchi; J Ohara; T Mosmann; W E Paul
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

10.  T-independent and T-dependent steps in the murine B cell response to antiimmunoglobulin.

Authors:  M L Birkeland; L Simpson; P C Isakson; E Pure
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

  10 in total
  12 in total

1.  Identical genetic control of MLC reactivity to different MHC incompatibilities, independent of production of and response to IL-2.

Authors:  V Holán; M Lipoldová; P Demant
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

2.  Loss of Th1-associated function in peripheral T cells but not thymocytes in tolerance to major histocompatibility complex alloantigen.

Authors:  P J Wood; I A Cossens
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

3.  Progressive changes in CD45RB phenotype and lymphokine production by murine CD4+ T cells after alloantigen exposure.

Authors:  M L Birkeland; T Kraus; L Tardelli; E Puré
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

4.  Allergen-dependent induction of interleukin-4 synthesis in vivo.

Authors:  X Yang; K T Hayglass
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

5.  The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.

Authors:  R A Seder; W E Paul; M M Davis; B Fazekas de St Groth
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

6.  T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense.

Authors:  J P Sypek; D J Wyler
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

7.  Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells.

Authors:  D B Lewis; C C Yu; J Meyer; B K English; S J Kahn; C B Wilson
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

8.  Distinct features of dendritic cells and anti-Ig activated B cells as stimulators of the primary mixed leukocyte reaction.

Authors:  J P Metlay; E Puré; R M Steinman
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

9.  T-independent and T-dependent B lymphoblasts: helper T cells prime for interleukin 2-induced growth and secretion of immunoglobulins that utilize downstream heavy chains.

Authors:  M S Forman; E Puré
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  The MRC OX-22- CD4+ T cells that help B cells in secondary immune responses derive from naive precursors with the MRC OX-22+ CD4+ phenotype.

Authors:  F Powrie; D Mason
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.